Aio peptides ApoA-I mimetic peptides are synthetic compounds designed to replicate the beneficial functions of apolipoprotein A-I (apoA-I), the primary protein component of high-density lipoprotein (HDL).作者：F Su·2010·被引用次数：249—ApoA-I mimetic peptidesreduced viability and proliferation of ID8 cellsand cis-platinum–resistant human ovarian cancer cells, and decreased ID-8 cell- ... These peptides hold significant promise as therapeutic agents, particularly for cardiovascular diseases, by mimicking apoA-I's antiatherogenic properties. Research into apoA-I mimetic peptides aims to leverage their ability to enhance reverse cholesterol transport, reduce inflammation, and promote vascular health, offering a simpler and potentially more potent alternative to HDL itselfAcute intravenous administration of anapoA-Iphospholipid complex has been shown to rapidly reduce plaque size in humans. In addition, short synthetic ....
ApoA-I is a crucial protein in lipid metabolism, playing a vital role in the removal of cholesterol from peripheral tissues and its transport back to the liver for excretion. This process, known as reverse cholesterol transport, is a key defense mechanism against atherosclerosisAn Apolipoprotein A-I Mimetic Peptide Designed with a .... ApoA-I mimetic peptides are engineered to capture the essential structural and functional elements of apoA-I, particularly its amphipathic helical nature, which is critical for interacting with lipids and cell membranes.作者：S Gou·2020·被引用次数：19—Apolipoprotein AI (apoA-I) mimetic peptides (AAMPs) are short peptides thatcan mimic the physiological effects of apoA-I, including the suppression of ... These synthetic peptides can mimic these physiological effects, including the suppression of atherosclerosisSafety, pharmacokinetics, and pharmacodynamics of oral ....
The therapeutic potential of apoA-I mimetic peptides stems from their ability to perform several critical functions associated with native apoA-I:
* Reverse Cholesterol Transport: Many apoA-I mimetic peptides are designed to activate enzymes like lecithin:cholesterol acyltransferase (LCAT), which are integral to the process of esterifying cholesterol and facilitating its efflux from cells. This action helps prevent the buildup of cholesterol in artery walls.
* Anti-inflammatory Effects: Beyond lipid management, these peptides have demonstrated significant anti-inflammatory properties. They can reduce monocyte infiltration and activation, a crucial step in the development of atherosclerotic plaques. For instance, the peptide 5A has shown efficacy in conditions like colitis by modulating inflammatory responses.
* Antioxidant Properties: ApoA-I mimetic peptides can increase antioxidant activity within the vasculature, further protecting against endothelial dysfunction and the progression of cardiovascular disease.ApoA-I Mimetic Peptides: A Review of the Present Status
* Vascular Protection and Angiogenesis: Some studies suggest that these peptides confer robust vascular protection and can promote physiological angiogenesis, the formation of new blood vessels, which is important for tissue repair and health.
* Potential in Other Diseases: Emerging research indicates that apoA-I mimetic peptides may have applications beyond cardiovascular healthThe ApoA-I mimetic peptide 5A enhances remyelination by .... For example, certain peptides have shown potential in reducing lipid deposition relevant to age-related macular degeneration (ARMD) and even in suppressing the viability and proliferation of specific cancer cells. Peptide 5A has also been investigated for its role in enhancing remyelination, suggesting potential in neurological conditions.作者：M Ditiatkovski·2013·被引用次数：38—Apolipoprotein A-I (apoA-I) mimetic peptidesare considered a promising novel therapeutic approach to prevent and/or treat atherosclerosis. An apoA-I mimetic ...
Several classes of apoA-I mimetic peptides have been developed and studied extensively.作者：BJ Van Lenten·2009·被引用次数：120—Among the best studiedapoA-I mimetic peptidesare the 4F peptides, which have been synthesized from both all D-amino acids (D-4F) and all L-amino acids (L-4F). The 4F peptides, including both all D-amino acid (D-4F) and all L-amino acid (L-4F) versions, are among the most well-researched作者：BJ Van Lenten·2009·被引用次数：120—Among the best studiedapoA-I mimetic peptidesare the 4F peptides, which have been synthesized from both all D-amino acids (D-4F) and all L-amino acids (L-4F).. D-4F, a synthetic peptide derived from D-amino acids, has shown significant promise in reducing atherosclerosis in animal models and has been evaluated in human trials for safety and efficacy. Another notable example is the Fukuoka Apo A-I Mimetic Peptide (FAMP), a 24-amino acid peptide designed without phospholipids. The peptide 5A has garnered attention for its ability to promote remyelination and its effectiveness in ameliorating inflammatory conditions. ETC-642 is another apoA-I mimetic peptide that has been studied for its anti-inflammatory effects.
ApoA-I mimetic peptides represent a significant advancement in the development of novel therapeutics.作者：BA Di Bartolo·2011·被引用次数：51—This study aimed to compare the anti-inflammatory effects ofETC-642, an apoA-I mimetic peptide, with that of discoidal reconstituted HDL (rHDL), consisting ... Their ability to mimic the multifaceted protective actions of apoA-I offers a compelling strategy for combating a range of diseases, with a particular focus on cardiovascular conditions. Ongoing research continues to refine the design and understand the mechanisms of these peptides, paving the way for potential new treatments that harness the body's own protective pathways.作者：GS Getz·2011·被引用次数：84—TheapoA-I mimetic peptideis a much simpler reagent for therapeutic purposes than HDL or apoA-I. It too may promote reverse cholesterol transport (not yet well. As research progresses, these synthetic molecules hold the potential to offer simpler, more potent, and targeted therapeutic interventions.
Join the newsletter to receive news, updates, new products and freebies in your inbox.